Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-02-16

Clinical Trial Update: Comparison of Desloratadine Associated With Prednisolone Oral Solution Versus Dexchlorpheniramine Associated With Betamethasone for Cutaneous Rash Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial comparing desloratadine with prednisolone oral solution versus dexchlorpheniramine with betamethasone for cutaneous hypersensitivity; the study st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desloratadine (desloratadine)
  • Dexchlorpheniramine (dexchlorpheniramine maleate)
  • Prednisolone (oral solution) (Prednisolone)
  • betamethasone (betamethasone)

Snippet

Sponsor: EMS | Conditions: Cutaneous Hypersensitivity | Phase 3 | Status: TERMINATED